|
|
Blood, 1 June 2005, Vol. 105, No. 11, pp. 4330-4336.
Prepublished online as a Blood First Edition Paper on February 10, 2005; DOI 10.1182/blood-2002-09-2942.
 Previous Article | Table of Contents | Next Article 
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
Identification and functional characterization of a novel 27-bp deletion in the macroglycopeptide-coding region of the GPIBA gene resulting in platelet-type von Willebrand disease
Maha Othman,
Colleen Notley,
Frances Louise Lavender,
Helen White,
Christopher D. Byrne,
David Lillicrap, and
Denise Frances O'Shaughnessy
From the Department of Pathology and Molecular Medicine, Queens University, Kingston, ON, Canada; and Molecular Pathology Unit, Department of Endocrinology and Metabolism, and Department of Hematology, Southampton University Hospitals NHS Trust, Southampton, United Kingdom.
Interaction between the platelet glycoprotein Ib (GPIb) receptor and its adhesive ligand von Willebrand factor (VWF) has a critical role in the process of hemostasis. Platelet-type von Willebrand disease (PT-VWD) is a rare bleeding disorder that results from gain-of-function mutations in the GPIBA gene. We studied this gene from 5 members of a previously unreported family with a PT-VWD phenotype. We identified a novel in-frame deletion of 27 base pair (bp) in the macroglycopeptide region. This deletion was not found in the unaffected family members or in 50 healthy controls. The patients' platelets expressed normal quantities of GPIb/IX/V complex on their surface and the mutant (Mut) GPIb was expressed at levels indistinguishable from the wild-type (WT) receptor on the surface of transfected Chinese hamster ovary (CHO)  /IX cells. Analysis of ristocetin-mediated 125I-VWF binding showed that the Mut receptor binds VWF in the absence of ristocetin and displays an increased sensitivity to lower concentrations of the modulator. This is the first report of a gain-of-function mutation in the GPIb receptor outside the VWF-binding domain in patients with PT-VWD. The mutation provides a molecular basis for the PT-VWD phenotype and supports a role for the macroglycopeptide region in receptor function.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
Related Article in Blood Online:
-
The mysteries of a platelet adhesion receptor
- Junmei Chen and José A. López
Blood 2005 105: 4154-4155.
[Full Text]
[PDF]
This article has been cited by other articles:
|
|
|
|
 
M. Diamandis, A. D. Paterson, J. M. Rommens, D. K. Veljkovic, J. Blavignac, D. E. Bulman, J. S. Waye, F. Derome, G. E. Rivard, and C. P. M. Hayward
Quebec platelet disorder is linked to the urokinase plasminogen activator gene (PLAU) and increases expression of the linked allele in megakaryocytes
Blood,
February 12, 2009;
113(7):
1543 - 1546.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. J. Suva, E. Hartman, J. D. Dilley, S. Russell, N. S. Akel, R. A. Skinner, W. R. Hogue, U. Budde, K. I. Varughese, T. Kanaji, et al.
Platelet Dysfunction and a High Bone Mass Phenotype in a Murine Model of Platelet-Type von Willebrand Disease
Am. J. Pathol.,
February 1, 2008;
172(2):
430 - 439.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Peng, C. N. Shrimpton, J.-f. Dong, and J. A. Lopez
Gain of von Willebrand factor-binding function by mutagenesis of a species-conserved residue within the leucine-rich repeat region of platelet glycoprotein Ib{alpha}
Blood,
September 15, 2005;
106(6):
1982 - 1987.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
